Afya Limited Announces Fourth-Quarter and Full-Year 2022 Financial Results

About this update from Afya Limited

[{"type":"text","content":"\nAnother Year of Strong Performance\n\nRobust EPS Expansion\n\nGuidance Achievement\n\n NOVA LIMA, Brazil--(BUSINESS WIRE)--\nAfya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2022. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).\n\nFourth Quarter 2022 Highlights\n\n\n4Q22 Adjusted Net Revenue increased 17.8% YoY to R$595.1 million.\n\n\n4Q22 Adjusted EBITDA increased 24.1% YoY, reaching R$242.2 million, with an Adjusted EBITDA Margin of 40.7%.\n\n\n4Q22 Adjusted Net Income increased 30.8% YoY, reaching R$128.8 million, with an EPS growth of 53.3% in the same period.\n\n\nFull-Year 2022 Highlights\n\n\nFY22 Adjusted Net Revenue increased 32.3% YoY to R$2,319.1 million.\n\n\nFY22 Adjusted EBITDA increased 27.4% YoY, reaching R$961.9 million, with an Adjusted EBITDA Margin of 41.5%.\n\n\nFY22 Adjusted Net Income increased 21.5% YoY, reaching R$535.1 million, with an EPS growth of 73.2% in the same period.\n\n\nCash conversion of 94.4%, with a solid cash position of R$1,093.1 million.\n\n\n~260 thousand monthly active physicians and medical students using Afya’s Digital Services, an increase of 5.3% over the same period last year.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\nTable 1: Financial Highlights\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFor the three months period ended December 31,\n\nFor the twelve months period ended December 31,\n\n\n(in thousand of R$)\n\n2022\n\n\n\n2022 Ex Acquisitions*\n\n\n\n2021\n\n\n\n% Chg\n\n\n\n% Chg Ex Acquisitions\n\n\n\n \n\n\n\n2022\n\n\n\n2022 Ex Acquisitions*\n\n\n\n2021\n\n\n\n% Chg\n\n\n\n% Chg Ex Acquisitions\n\n\n\n\n(a) Net Revenue\n\n584,002\n\n\n\n574,027\n\n\n\n498,259\n\n\n\n17.2%\n\n\n\n15.2%\n\n\n\n\n2,329,057\n\n\n\n2,036,612\n\n\n\n1,719,371\n\n\n\n35.5%\n\n\n\n18.5%\n\n\n\n\n(b) Adjusted Net Revenue (1)\n\n595,138\n\n\n\n585,163\n\n\n\n505,407\n\n\n\n17.8%\n\n\n\n15.8%\n\n\n\n\n2,319,131\n\n\n\n2,026,686\n\n\n\n1,752,728\n\n\n\n32.3%\n\n\n\n15.6%\n\n\n\n\n(c) Adjusted EBITDA (2)\n\n242,207\n\n\n\n239,390\n\n\n\n195,128\n\n\n\n24.1%\n\n\n\n22.7%\n\n\n\n\n961,924\n\n\n\n828,497\n\n\n\n754,836\n\n\n\n27.4%\n\n\...

More updates from Afya Limited